Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4756811
Max Phase: Preclinical
Molecular Formula: C41H46N4O4
Molecular Weight: 658.84
Molecule Type: Unknown
Associated Items:
ID: ALA4756811
Max Phase: Preclinical
Molecular Formula: C41H46N4O4
Molecular Weight: 658.84
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(C(C)=O)c(N5CCN(C(=O)[C@@H]6CCCN6C(=O)c6ccc7ccccc7n6)CC5)cc4[C@H]3CC[C@@]21C
Standard InChI: InChI=1S/C41H46N4O4/c1-4-41(49)18-16-33-30-13-11-28-24-31(26(2)46)37(25-32(28)29(30)15-17-40(33,41)3)43-20-22-44(23-21-43)39(48)36-10-7-19-45(36)38(47)35-14-12-27-8-5-6-9-34(27)42-35/h1,5-6,8-9,12,14,24-25,29-30,33,36,49H,7,10-11,13,15-23H2,2-3H3/t29-,30+,33-,36-,40-,41-/m0/s1
Standard InChI Key: OXSHJGKXDFBYET-MNTHMHGSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 658.84 | Molecular Weight (Monoisotopic): 658.3519 | AlogP: 5.61 | #Rotatable Bonds: 4 |
Polar Surface Area: 94.05 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 8 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: 3.27 | CX LogP: 5.07 | CX LogD: 5.07 |
Aromatic Rings: 3 | Heavy Atoms: 49 | QED Weighted: 0.29 | Np Likeness Score: -0.23 |
1. Maltais R,Perreault M,Roy J,Poirier D. (2020) Minor chemical modifications of the aminosteroid derivative RM-581 lead to major impact on its anticancer activity, metabolic stability and aqueous solubility., 188 [PMID:31893547] [10.1016/j.ejmech.2019.111990] |
Source(1):